Adalimumab, a tumor necrosis factor inhibitor, was associated with an early reduction in epicardial adipose tissue in people ...

In adults with psoriasis, adding methotrexate to adalimumab did not improve effectiveness or drug survival compared with adalimumab alone, according to a UK cohort study of patients with plaque ...

Adalimumab biosimilar AVT02 exhibited comparative efficacy, safety, tolerability, and immunogenicity to the reference drug Humira in patients with moderate-to-severe chronic plaque psoriasis. The ...

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest ...

Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread adoption. This analysis involving patients in the U.K. and Ireland provides ...

Biosimilars demonstrate comparable drug survival and safety with adalimumab among new users, but patients switching from Humira (the originator product) to biosimilars had a 35% higher discontinuation ...

plaque psoriasis The efficacy, safety, pharmacokinetics, and immunogenicity of adalimumab combined with MTX compared with that adalimumab in patients with chronic plaque psoriasis is evaluated. Adding ...

Please provide your email address to receive an email when new articles are posted on . Patients with psoriasis who were treated with ixekizumab were more likely to adhere to therapy compared with ...

Medically reviewed by Casey Gallagher, MD Key Takeaways Clobex spray is a powerful corticosteroid that can clear psoriasis symptoms in about four weeks.Cyclosporine is a fast-acting immunosuppressant ...

Share on Pinterest Humira will soon have a citrate-free biosimilar available on the market. Humira (adalimumab) is a popular medication used to treat various inflammatory conditions including ...

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...